Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To explore the role and the rule of
leptin
levels in severe traumatism, an ischemia-reperfusion injury model was established to observe change of
leptin
levels, and platelet activating factor, noradrenaline,
lipopolysaccharide
, and endothelin-1 were utilized to induce vascular endothelial cells. Leptin concentrations in serum and supernatant were detected by murine and human
leptin
radioimmunoassay. The results showed that the first serum
leptin
level significantly decreased after an injury of 60 min ischemia and 30 min reperfusion versus pre-experimental serum values, and
leptin
level in serum showed a variational trend to increase as reperfusion time extended; the second, supernatant
leptin
level significantly decreased after PAF and ET-1 treatments of 6 and 24 h versus the control group. It can be concluded that
leptin
maybe an inflammatory cytokine to play a protection role in acute inflammation and traumatism.
...
PMID:Intestinal ischemia-reperfusion injury made leptin decreased. 1627 74
Bacterial and viral products, such as bacterial
lipopolysaccharide
(
LPS
), cause inducible (i) NO synthase (NOS) synthesis, which in turn produces massive amounts of nitric oxide (NO). NO, by inactivating enzymes and leading to cell death, is toxic not only to invading viruses and bacteria, but also to host cells. Injection of
LPS
induces interleukin (IL)-1beta, IL-1alpha, and iNOS synthesis in the anterior pituitary and pineal glands, meninges, and choroid plexus, regions outside the blood-brain barrier. Thereafter, this induction occurs in the hypothalamic regions (such as the temperature-regulating centers), paraventricular nucleus (releasing and inhibiting hormone neurons), and the arcuate nucleus (a region containing these neurons and axons bound for the median eminence). Aging of the anterior pituitary and pineal with resultant decreased secretion of pituitary hormones and the pineal hormone melatonin, respectively, may be caused by NO. The induction of iNOS in the temperature-regulating centers by infections may cause the decreased febrile response in the aged by loss of thermosensitive neurons. NO may play a role in the progression of Alzheimer's disease and parkinsonism.
LPS
similarly activates cytokine and iNOS production in the cardiovascular system leading to coronary heart disease. Fat is a major source of NO stimulated by
leptin
. As fat stores increase,
leptin
and NO release increases in parallel in a circadian rhythm with maxima at night. NO could be responsible for increased coronary heart disease as obesity supervenes. Antioxidants, such as melatonin, vitamin C, and vitamin E, probably play important roles in reducing or eliminating the oxidant damage produced by NO.
...
PMID:The nitric oxide theory of aging revisited. 1639 88
Leptin secreted mainly by adipocytes plays an important role in insulin sensitivity in metabolic syndrome. Inducible nitric oxide synthase (iNOS) in 3T3-L1 adipocytes is induced by
lipopolysaccharide
(
LPS
) and several proinflammatory cytokines such as tumor necrosis factor-alpha and interferon-gamma (IFN-gamma). Because the role of iNOS-derived nitric oxide (NO) in adipocyte function has not been fully clarified, the question that we addressed in the present study was whether iNOS-derived NO is involved in regulation of
leptin
secretion by adipocytes. Incubation of 3T3-L1 adipocytes for 12h with a mixture of IFN-gamma and
LPS
caused not only a 55% reduction in
leptin
secretion and a 52% reduction in
leptin
mRNA, but also significant induction of iNOS at both protein and mRNA levels. Inhibition of
leptin
secretion that had been induced by the IFN-gamma-
LPS
mixture was completely nullified by NOS inhibitors such as Nomega-monomethyl-L-arginine and aminoguanidine. Treatment of adipocytes with NO donors such as an NONOate and S-nitrosoglutathione produced an effect on
leptin
secretion similar to that of the IFN-gamma-
LPS
mixture. It is likely therefore that NO mediates downregulation of
leptin
caused by the IFN-gamma-
LPS
mixture in 3T3-L1 adipocytes, which suggests an important role for NO in adipocyte functions.
...
PMID:Nitric oxide-induced downregulation of leptin production by 3T3-L1 adipocytes. 1644 19
Muscle growth in meat animals is a complex process governed by integrated signals emanating from multiple endocrine and immune cells. A generalized phenomenon among meat animal industries is that animals commonly fail to meet their genetic potential for growth in commercial production settings. Therefore, understanding the impact of stress and disease on muscle growth is essential to improving production efficiency. The adipocyte in particular seems to be well positioned as an interface between energy status and immune function, and may thus influence nutrient partitioning and growth through a combination of signals that influence fat metabolism, glucose uptake, and insulin sensitivity. Adipocytes and myofibers are active participants in the innate immune response, and as such, produce a number of metabolic regulators, including
leptin
, adiponectin, and proinflammatory cytokines. Specifically, adipocytes and muscle cells respond directly to bacterial
lipopolysaccharide
(
LPS
) by producing interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFalpha). However, adipocytes are also the predominant source of the antiinflammatory hormone adiponectin, which regulates the nuclear factor kappa-B transcription factor. The ability to recognize antigens and produce regulatory molecules strategically positions adipocytes and myofibers to regulate growth locally, and to reciprocally regulate metabolism peripherally.
...
PMID:Adipocytes, myofibers, and cytokine biology: new horizons in the regulation of growth and body composition. 1658 86
Pro-inflammatory cytokines, interleukin (IL)-1beta, IL-6 and tumor necrosis factor-alpha (TNF-alpha) synthesized by activated macrophages and monocytes in response to administration of
lipopolysaccharide
(
LPS
), are considered important mediators of fever and sickness behavior. We administered rat-specific antisera for TNF-alpha, IL-1beta, IL-6 and
leptin
, to determine the involvement of peripherally released cytokines in
LPS
-induced fever and sickness behavior, measured as suppression of voluntary wheel-running and food intake. Male Sprague-Dawley rats (approximately 200 g) selected for their predisposition to spontaneously run on running wheels were anaesthetized with a combination of ketamine hydrochloride (80 mg/kg i.m.) and xylazine (4 mg/kg i.m.) and implanted intra-abdominally with temperature-sensitive radiotelemeters. Rats were injected intraperitoneally with anti-rat sera to one of the following, TNF-alpha, IL-1beta, IL-6 or
leptin
or with pre-immune sheep serum, followed by a subcutaneous injection of either
LPS
(250 microg/kg) or sterile saline. Lipopolysaccharide administration induced a approximately 1.3 (0.2) degrees C fever lasting approximately 10 h and reduced voluntary running by 93 (8.6)% and food intake by 51 (21.3)% compared to the saline response (ANOVA, P<0.05). Injection of anti-IL-6 serum or anti-
leptin
serum abolished the
LPS
-induced fever, anti-TNF-alpha serum affected only the early phase of fever and anti-IL-1beta serum had no effect on fever (ANOVA, P<0.05).
LPS
-induced suppression of voluntary running and food intake were attenuated in rats receiving anti-IL-6 serum, while the decrease in food intake was totally abolished in rats receiving anti-
leptin
serum (ANOVA, P<0.05). Injection of anti-TNF-alpha or anti-IL-1beta serum had no effect on
LPS
-induced sickness behavior. Peripherally released IL-6 and
leptin
therefore appear to be important in regulating
LPS
-induced fever and sickness behavior.
...
PMID:Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. 1684 30
N-Palmitoylethanolamide (PEA) is an endogenous lipid secreted by human adipocytes that possesses numerous anti-inflammatory properties. Human adipose tissue can be subjected to modulation of its inflammatory state by
lipopolysaccharide
(
LPS
). Here we demonstrate that
LPS
increases the secretion of interleukin-6 (IL-6) by human mature adipocytes via activation of the NFkappaB pathway. This effect is not inhibited by PEA. Inversely,
LPS
strongly inhibits adipose cell
leptin
release, with PEA acting as a potentiator of this inhibitory effect. These actions are not linked to a reduction in
leptin
gene transcription. Thus, PEA does not have an anti-inflammatory role in the secretion of IL-6 via NFkappaB at the adipocyte level, but instead seems to act at the heart of the
LPS
-stimulated pathway, which, independently of NFkappaB, inhibits the secretion of
leptin
.
...
PMID:Effect of PEA on LPS inflammatory action in human adipocytes. 1688 8
The blood-brain barrier (BBB) prevents the unrestricted movement of peptides and proteins between the brain and blood. However, some peptides and regulatory proteins can cross the BBB by saturable and non-saturable mechanisms. Leptin and insulin each cross the BBB by their own transporters. Impaired transport of
leptin
occurs in obesity and accounts for peripheral resistance; that is, the condition wherein an obese animal loses weight when given
leptin
directly into the brain but not when given
leptin
peripherally. Leptin transport is also inhibited in starvation and by hypertriglyceridemia. Since hypertriglyceridemia occurs in both starvation and obesity, we have postulated that the peripheral resistance induced by hypertriglyceridemia may have evolved as an adaptive mechanism in response to starvation. Insulin transport is also regulated. For example, treatment of mice with
lipopolysaccharide
(
LPS
) increases insulin transport across the BBB by about threefold. Since many of the actions of CNS insulin oppose those of peripheral insulin and since
LPS
releases proinflammatory cytokines, enhanced transport of insulin across the BBB could be a mechanism which promotes insulin resistance in sepsis. The brain endothelial cells which comprise the BBB secrete many substances including cytokines. Such secretion can be stimulated from one side of the BBB with release into the other side. For example, it appears that adiponectin can inhibit release of interleukin-6 from brain endothelial cells. Overall, the BBB represents an important interface in mediating gut-brain axes.
...
PMID:The blood-brain barrier as a regulatory interface in the gut-brain axes. 1690 39
The blood-brain barrier (BBB) plays a critical role in the transduction of signals between the central nervous system and peripheral tissues. It does so through several mechanisms, including the direct transport of peptides and regulatory proteins such as insulin and
leptin
. Another mechanism that may be important is the secretion by brain endothelial cells of substances that affect feeding, such as proinflammatory cytokines and NO. We have recently shown that the BBB is capable of receiving an input from one side and secreting a substance into the other. Additionally, BBB secretions can be modulated by substances that affect feeding, such as adiponectin and
lipopolysaccharide
.
...
PMID:Blood-brain barrier and energy balance. 1702 73
A small percentage of pathologically obese subjects with fatty livers develop histological signs of necroinflammation and fibrosis, suggesting a variety of cofactors in the pathogenesis of obesity-related liver diseases including nonalcoholic steatohepatitis. Since several observations have linked bacterial endotoxins to liver damage, the aim of this study was to determine the effect of obesity on intestinal mucosal integrity and portal blood endotoxemia in two strains of obese mice:
leptin
-deficient (ob/ob) and hyperleptinemic (db/db) mice. Murine intestinal mucosal barrier function was assessed using a Ussing chamber, whereas ileum tight junction proteins were analyzed by immunocytochemistry and Western blot analysis. Circulating proinflammatory cytokines and portal blood endotoxin levels were measured by ELISA and the limulus test, respectively. The inflammatory and fibrogenic phenotype of murine hepatic stellate cells (HSCs) was determined by ELISA and quantitative RT-PCR. Ob/ob and db/db mice showed lower intestinal resistance, profoundly modified distribution of occludin and zonula occludens-1 in the intestinal mucosa, and higher circulating levels of inflammatory cytokines and portal endotoxemia compared with lean control mice. Moreover, HSCs isolated from ob/ob and db/db mice showed higher membrane CD14 mRNA levels and more pronounced
lipopolysaccharide
-induced proinflammatory and fibrogenic responses than HSCs from lean animals. In conclusion, genetically obese mice display enhanced intestinal permeability leading to increased portal endotoxemia that makes HSCs more sensitive to bacterial endotoxins. We suggest that in metabolic syndrome, patients may likewise have a greater intestinal mucosa permeability and increased
lipopolysaccharide
levels in portal blood that can contribute to the liver inflammatory damage.
...
PMID:Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. 1702 54
In addition to its central effects on appetite regulation,
leptin
has been implicated in immune function and inflammation. Previous data suggested that
leptin
acts as an inflammatory signal within the brain, as exogenously administered
leptin
induced fever, a typical brain-regulated inflammatory response. The present study aimed to delineate the inflammatory actions and cellular targets of
leptin
in the brain by examining its effects on the expression of interleukin (IL)-1beta and cyclooxygenase (COX)-2, two important inflammatory components of the fever response. Intracerebroventricular injection of
leptin
(5 microg/rat) induced IL-1beta and COX-2 mRNA and protein in the hypothalamus between 1 and 3 h after treatment as determined by reverse transcription-polymerase chain reaction and immunohistochemistry. Coinjection of IL-1 receptor antagonist (100 microg/rat, intracerebroventricular) attenuated
leptin
-induced COX-2, whereas IL-1 receptor antagonist had no effect on endogenous IL-1beta levels, suggesting that
leptin
induces COX-2 via, at least partly, IL-1beta action. IL-1beta protein expression was induced in macrophages in the meningis and perivascular space after
leptin
treatment, whereas COX-2 induction was observed in endothelial cells, indicating the roles for these non-neuronal cells in mediating inflammatory actions of
leptin
. In addition, neutralization of endogenous circulating
leptin
with anti-
leptin
antiserum attenuated intraperitoneal
lipopolysaccharide
(100 microg/kg)-induced brain IL-1beta and COX-2 upregulation, suggesting that
leptin
indeed acts as an inflammatory signal to the brain during systemic inflammation. These findings are in contrast to the effects of
leptin
on appetite regulation where it is believed to act primarily on neurons, thus presenting a distinct anatomical basis for the inflammatory and appetite regulatory actions of
leptin
in the brain.
...
PMID:Leptin induces cyclooxygenase-2 via an interaction with interleukin-1beta in the rat brain. 1707 47
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>